Hong Kong – Linklogis HK$8.0 Billion IPO.

Davis Polk advised Linklogis Inc. in connection with its initial public offering and listing on the Hong Kong Stock Exchange and an international offering in reliance on Rule 144A and Regulation S. ( read original story ...)

Keymed gears up for Hong Kong IPO

Keymed Biosciences has started laying the groundwork for a planned Hong Kong IPO by filing its initial listing documents with the city’s exchange. ( read original story ...)